Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Massard

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCCY Loriot, C Massard, E Angevin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 11, 2017
[Management of a progressing prostate cancer: results of a national study]F Rozet, M Roupret, C Hennequin, et al.
Onkologie|March 11, 2010
Can a cure be achieved with taxane-based chemotherapy plus surgery in patients with primary mediastinal non-seminomatous germ cell tumors and progression or relapse despite first-line chemotherapy?Vera Miskovska, Antonin Levy, Christophe C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Bevacizumab-induced laryngeal necrosisD M Hartl, R Bahleda, A Hollebecque, et al.
Investigational New Drugs|August 30, 2008
Rhinitis and epistaxis in patients treated by anti-angiogenic therapyV Prulière-Escabasse, E Escudier, R Balheda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2011
Thrombotic microangiopathy related to anti-VEGF agents: intensive versus conservative treatment?H Izzedine, D Sène, J Hadoux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2015
Enzalutamide and sleep apnea: an emerging central nervous system side-effect?F Labrize, L Cany, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2020
Sequential treatment with NOTCH inhibitor crenigacestat followed by pazopanib in soft tissue sarcoma patientsO Mir, S Watson, C Massard, et al.
Annales De Dermatologie Et De Venereologie|October 22, 2008
[Eruptive nevi associated with sorafenib treatment]M Bennani-Lahlou, C Mateus, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Risk factors for brain relapse in patients with metastatic breast cancerK Slimane, F Andre, S Delaloge, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCCY Loriot, C Massard, E Angevin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 11, 2017
[Management of a progressing prostate cancer: results of a national study]F Rozet, M Roupret, C Hennequin, et al.
Onkologie|March 11, 2010
Can a cure be achieved with taxane-based chemotherapy plus surgery in patients with primary mediastinal non-seminomatous germ cell tumors and progression or relapse despite first-line chemotherapy?Vera Miskovska, Antonin Levy, Christophe C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Bevacizumab-induced laryngeal necrosisD M Hartl, R Bahleda, A Hollebecque, et al.
Investigational New Drugs|August 30, 2008
Rhinitis and epistaxis in patients treated by anti-angiogenic therapyV Prulière-Escabasse, E Escudier, R Balheda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2011
Thrombotic microangiopathy related to anti-VEGF agents: intensive versus conservative treatment?H Izzedine, D Sène, J Hadoux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2015
Enzalutamide and sleep apnea: an emerging central nervous system side-effect?F Labrize, L Cany, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2020
Sequential treatment with NOTCH inhibitor crenigacestat followed by pazopanib in soft tissue sarcoma patientsO Mir, S Watson, C Massard, et al.
Annales De Dermatologie Et De Venereologie|October 22, 2008
[Eruptive nevi associated with sorafenib treatment]M Bennani-Lahlou, C Mateus, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Risk factors for brain relapse in patients with metastatic breast cancerK Slimane, F Andre, S Delaloge, et al.
Pageof 9